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Abstract:  Monocytes  play  several  significant  immunological  roles  during  HIV  infection.  The 
phenotypic pliability and the cellular differentiation ability monocytes possess are crucial to the ways 
they combat infections and control inflammatory processes. The purpose of this review is to provide a 
comprehensive  snapshot  of  the  importance  of  monocytes  in  HIV-1  infection  and  pathogenesis. 
Moreover, this review also provides newly emerging data on how HIV leads to the subversion and 
manipulation of monocyte transcriptome and proteome, which may have implications in understanding 
the genomic and proteomic basis of monocyte function and its interaction with HIV.  
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INTRODUCTION 
 
  According  to  the  UNAIDS  estimate,  34  million 
people around the world were living with HIV at the 
end of 2010; 17% more people living with HIV than in 
2001.  It  is  estimated  that  2.7  million  people  became 
infected in 2010, including close to 400000 children. 
This  means  that  AIDS  remains  one  of  the  most 
significant  infectious  diseases  worldwide  and  these 
figures are not likely to decrease, with over 7300 people 
becoming  infected  with  HIV  every  day 
(UNAIDS/WHO, 2010).  
  The causative agent of AIDS was first reported in 
1983 (Barre-Sinoussi et al., 1983), which was named 
Human Immunodeficiency Virus (HIV) (Coffin et al., 
1986).  HIV  has  two  major  sub-species:  the  more 
common HIV type 1 (HIV-1) and the less prominent 
HIV  type  2  (HIV-2),  which  was  discovered  in  West 
Africa in 1986 (Clavel et al., 1986). HIV-2 can also 
cause AIDS (Rowland-Jones and Whittle, 2007), but it 
has remained localized to west Africa and the reasons 
for  its  very  low  infectious  potential  and  inefficient 
global spread remain unexplained. In contrast, HIV-1 
has  successfully  spread  across  the  globe  and  is 
responsible  for  the  current  global  AIDS  pandemic. 
Although HIV infects primarily the CD4+T cells, it has 
the  ability  to  infect  all  major  blood  leukocytes, 
including monocytes (Saksena and Potter, 2003).  
Monocytic phenotypes in vivo: There are two types of 
monocytes  in  the  human  blood:  (a)  the  classical 
monocyte,  which  is  characterized  by  high  level 
expression  of  the  CD14  cell  surface  receptor 
(CD14++monocyte)  and  (b)  the  non-classical,  pro-
inflammatory  monocyte  with  low  level  expression  of 
CD14 and with additional co-expression of the CD16 
receptor  (CD14+CD16+monocyte)  (Ziegler-Heitbrock, 
2007). The CD14+CD16+monocytes develop from the 
CD14++monocytes,  i.e.,  they  are  a  more  mature 
version. Following stimulation with microbial products 
the CD14+CD16+monocytes produce copious amounts 
of  pro-inflammatory  cytokines  like  Tumor  Necrosis 
Factor (TNF) and interleukin-12 (IL-12). 
 
Functional attributes of Monocytes: In humans, about 
3-8% of blood leukocytes is comprised of monocytes 
and is produced by the bone marrow from monoblasts-
the  haematopoietic  stem  cell  precursors.  Recently, 
scientists from the Massachusetts General Hospital and 
Harvard Medical School demonstrated that the spleen is 
a reservoir for huge numbers of monocytes. A current 
paradigm  states  that  monocytes  circulate  freely  and 
patrol  blood  vessels  but  irreversibly  differentiate  into 
Dendritic  Cells  (DCs)  or  macrophages  upon  tissue 
entry. They show clear evidence that  undifferentiated 
monocytes  reside  in  the  spleen  and  outnumber  their 
equivalents  in  systemic  circulation.  Normally, 
monocytes  are  known  to  systemically  circulate  for Am. J. Infect. Dis., 8 (2): 92-105, 2012 
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about  one  to  three  days  before  moving  into  tissues 
throughout the body. The reservoir monocytes assemble 
in clusters in the cords of the sub-capsular red pulp and 
are  distinct  from  macrophages  and  DCs.  These 
observations have uncovered a role for the spleen as a 
site  for  storage  and  rapid  deployment  of  monocytes 
and identify splenic monocytes as a resource that the 
body  exploits  to  regulate  inflammatory  processes 
(Swirski et al., 2009). These observations have created 
a new paradigm that will significantly shift the way 
we  perceive  monocytes  in  the  context  of  HIV 
infection  and  their  deployment  and  sequestration  to 
inflammation sites in vivo.  
  Monocytes  play  several  significant  roles  in  the 
immune  system;  (1)  they  replenish  resident 
macrophages  and  dendritic  cells  under  normal  states, 
(2)  they,  in  response  to  inflammation  signals,  move 
quickly  (approx.  8-12  h.)  to  sites  of  infection  in  the 
tissues  and  divide/differentiate  into  macrophages  and 
dendritic cells to elicit an immune response and (3) they 
can  perform  phagocytosis  using  intermediary 
(opsonising) proteins such as antibodies or complement 
that  coat  the  pathogen,  as  well  as  by  binding  to  the 
microbe directly via pattern-recognition receptors that 
recognize pathogens. They are also capable of killing 
infected  host  cells  via  antibody,  termed  antibody-
mediated  cellular  cytotoxicity.  Thus,  the  blood 
monocytes  are  young  cells  that  already  possess 
migratory,  chemotactic,  pinocytic  and  phagocytic 
activities,  as  well  as  receptors  for  IgG  Fc-domains 
(FcR)  and  iC3b  complement.  Upon  migration  into 
tissues,  monocytes  undergo  further  differentiation  to 
become  multifunctional  tissue  macrophages. 
Monocytes,  therefore,  are  considered  to  be  immature 
macrophages.  It  can  also  be  argued  that  monocytes 
represent  the  circulating  macrophage  population  and 
therefore should be considered fully functional for their 
location as they can change their phenotype in response 
to factors encountered in specific tissue post-migration. 
 
HIV infection of diverse blood leukocytes including 
Monocytes: 
HIV infection of blood leukocytes: HIV is capable of 
infecting cells of diverse types. A  wide-range of cell 
types distributed amongst a number of different tissues 
is  susceptible  to  HIV  infection.  CD4+T  lymphocytes 
(Klatzmann et al., 1984; Schnittman et al., 1989) and 
macrophages (Gartner et al., 1986; Ho et al., 1986) are 
the  primary  cellular  targets  of  HIV.  Other  infectable 
cell  types  include  monocytes,  CD8+T  lymphocytes, 
Natural Killer (NK) cells, dendritic cells, B cells and an 
array  of  specialized  cell  types  derived  from  various 
tissue  reservoirs  of  HIV  (e.g.,  renal,  mucosal  and 
cervical epithelial cells, astrocytes and microglia in the 
CNS,  skin  fibroblasts,  bone  marrow  stem  cells). 
However, the infection of a number of putative cellular 
HIV  targets  remains  controversial  and  therefore  the 
actual  estimate  of  their  contribution  to  HIV 
pathogenesis is often unclear.  
  HIV-1 can infect cells by two mechanisms, either 
by the attachment of cell-free virions, or by the direct 
passage  of  HIV-1  between  infected  and  uninfected 
cells.  HIV  usually  disseminates  by  a  direct  cell-cell 
transfer mechanism in densely populated tissues, such 
as between T lymphocytes in the lymph nodes. Jolly et 
al. (2004) showed that this direct passage of HIV-1 is 
centered  on  an  adhesive  junction,  where  by  HIV-1 
virions can move through and infect the target cell. This 
adhesive  junction  contains  CD4  and  chemokine 
receptors, as well as adhesion molecules suchas LFA-1 
and  ICAM-1.  These  receptors  are  up-regulated  and 
migrate  to  the  synapse  via  an  actin-dependent 
mechanism (Jolly et al., 2004). This up-regulation and 
migration  of  receptors  is  probably  initiated  by  the 
attachment of initial Env glycoproteins to CD4 and the 
chemokine  receptor,  which  in  turn  induces  the 
recruitment of more receptors.  
 
Monocytes:  In  the  context  of  HIV,  the  infection  of 
circulating blood monocytes was first reported early in 
the  epidemic  (Gartner  et  al.,  1986;  Ho  et  al.,  1986; 
(McElrath et al., 1989; 1991). These initial reports did 
not clarify as to whether monocyte infection is latent or 
productive. Subsequent studies found levels of proviral 
DNA in monocytes to be relatively low or undetectable 
in comparison to T cell compartments (Innocenti et al., 
1992;  Livingstone  et  al.,  1996).  However,  more 
sophisticated  approaches  using  in  situ  hybridization 
coupled with simultaneous surface immuno-phenotyping 
revealed a higher incidence of monocyte infection and 
demonstrated  the  production  of  viral  mRNA  in 
monocytes indicating productive infection (Patterson et 
al., 1993; 1995; 1999). Despite the apparent production 
of viral mRNA, other in vitro studies indicated that HIV 
replication was blocked prior to reverse transcription and 
integration  (Sonza  et  al.,  1996).  Following  this, 
replication competent virus was shown to be recoverable 
from  blood-derived  monocytes  upon  stimulation  and 
differentiation  into  macrophages  (Lambotte  et  al., 
2000). But one is to be cautious as other contaminant 
cell types with monocytes can lead to misinterpretation 
of actual infection of monocytes by HIV. 
  The  HIV  envelope  protein  gp120  must  interact 
with  both  CD4  receptor  and  a  co-receptor  to  trigger 
fusion  of  the  viral  and  cellular  membranes  and  gain 
entry into the target cells. The ability to bind to specific 
co-receptors is a critical determinant of the cell tropism Am. J. Infect. Dis., 8 (2): 92-105, 2012 
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of different HIV-1 strains. For example, binding to the 
α-chemokine receptor CXCR4 is a definitive feature of 
strains that infect T-cell lines, where as binding to the 
β-chemokine  receptor  CCR5  is  characteristic  of  M-
tropic  strains,  which  primarily  infect  monocytes  and 
macrophages. There is direct association between levels 
of  CCR5  and  differentiation  of  monocytes  to 
macrophages. Levels of CCR5 are related to monocyte 
resistance  and  macrophage  susceptibility  to  infection 
because the infection by the M-tropic strain HIV-1JRFL 
could  be  blocked  by  MAb  2D7.  This  direct  evidence 
suggests that CCR5 functions as a co-receptor for HIV-1 
infection of primary macrophages (Tuttle et al., 1998). 
Further, it has also been shown that the CCR5 expression 
correlates with the susceptibility of maturing monocytes 
to HIV-1 infection (Naif et al., 1998).  
  Monocytes express both CD4 receptor and CCR5 
and  CXCR4  co-receptors,  so  HIV-1  viral  entry  into 
monocytes  is  possible  (Joly  and  Pinto,  2005). 
Therefore, the control of viral infection in monocytes is 
thought  to  take  place  during  the  early  phases  of 
infection, after  viral entry.  Arfi et al. (2008) showed 
that monocytes are susceptible to HIV-1, but the cells 
display several defects during HIV-1 infection, such as 
a slow reverse transcription and delayed nuclear import 
and  integration  (Arfi  et  al.,  2008).  Synthesis  of  viral 
DNA molecules is completed very slowly in monocytes, 
as  reverse  transcription  take  place  over  days  after 
infection. The majority of functional viral genomes are 
completed  by  day  4-5  post  infection  and  then  5-6 
additional days to integrate (Arfi et al., 2008). This delay 
in integration of viral DNA into host chromosomal DNA 
can be due to trafficking, nuclear import, or even post-
nuclear-import defects specifically present in monocytes. 
However, these defects delay, but do not diminish, the 
ability of HIV-1 to infect monocytes.  
  Overall,  the  productive  infection  of  monocytes 
appears  to  be  governed  by  changes  in  environmental 
conditions.  Together,  the  changes  in  serum 
concentration, HIV strain (even at low passage), donor 
source  of  the  monocyte/macrophage  and  the  state  of 
cellular maturation appear to influence HIV replication 
in  monocytes.  Thus,  it  is  likely  that  the  host-genetic 
differences  may  contribute  to  differences  in  HIV 
replication  in  monocyte-derived  macrophages  and 
consequently to tissue virus load in vivo (Chang et al., 
1994). Furthermore, defective immunological function 
of  cells  of  the  macrophage  lineage  contributes 
considerably  to  the  pathogenesis  of  HIV-1  infection. 
Following  HIV-1  infection,  effector  functions  carried 
out  by  monocyte/macrophages  are  also  impaired, 
including  phagocytosis,  intracellular  killing, 
chemotaxis  and  cytokine  production.  Such  defects 
contribute  to  the pathogenesis  of  AIDS  by  allowing 
reactivation  and  development  of  opportunistic 
infections (Kedzierska et al., 2003a).  
 
Vital  contribution  of  Monocytes  in  HIV  antigen 
presentation:  Monocytes  are  important  in  antigen 
presentation to T cells during HIV infection. Defective 
antigen presentation by HIV+monocytes is a problem in 
HIV  isease  and  its  systematic  impairment  occurs  at 
each stage of plasma viremia. Furthermore, it has been 
shown that class II expression, formation of class II-Ag 
complexes and Ag uptake are impaired in chronically 
HIV-1-infected monocytic cells, which may contribute 
to  the  global  immunosuppression  observed  in  AIDS 
(Polyak  et  al.,  1997).  This  defective  antigen 
presentation  is  possibly  related  to  severe  immune 
dysfunction in HIV+patients. The mechanism by which 
this process occurs is not clear, but it appears that the 
reduced  capacity  by  HIV-infected  monocytes  to 
stimulate or present antigen to CD4+T-cells is mediated 
by  cellular  factors  associated  with  the  plasma 
membranes of HIV-infected monocytes, but the soluble 
factors secreted by HIV-infected monocytes have little 
or  no  effect  on  T-cell  stimulation.  Thus,  the  altered 
capacity  of  HIV-infected  monocytes  to  stimulate  and 
present  antigen  to  CD4+T-cells  is  related  to  down-
modulation of CD4 expression on T-cells and appears 
to  occur  via  membrane-associated  cellular  factors  on 
HIV-infected monocytes (Louie et al., 1996). Another 
underlying  reason  could  be  the  induction  of  TNF  by 
gp120,  which  may  be  associated  with  impairment  of 
antigen-presenting apacity of monocytes seen in AIDS 
patients (Zembala et al., 1994).  
 
Role of soluble CD14 as a marker and its correlation 
with  HIV  disease:  CD14  is  a  55-kDa 
Glycosylphosphatidylinositol  (GPI)-linked  protein 
present  on  the  surface  membrane  of  phagocytic 
leukocytes. It is also present in a soluble form in serum. 
Soluble (s) CD14 is a marker for monocyte/macrophage 
activation  and  a  mediator  of  bacterial 
Lipopolysaccharide  (LPS)  action.  The  complex 
glycolipid lipopolysaccharide (LPS), a cell membrane 
component  of  gram-negative  bacteria,  is  a  potent 
immune  stimulant.  This  immune  stimulation  is 
associated  with  the  binding  of  this  complex  with  the 
CD14/Toll-like receptor-4 (TLR-4) complex (Takeuchi 
et al., 2000). CD14, the primary LPS receptor, exists as 
both  cell  surface  membrane-bound  (mCD14)  and 
soluble  forms  (sCD14)  (Schutt,  1999).  mCD14  is 
expressed  on  the  cell  surface  of  cells  from  the 
monocyte/macrophage lineage (Takeuchi et al., 2000) 
and sCD14 is likely to represent the mCD14 which has 
been shed in response to either monocyte activation or Am. J. Infect. Dis., 8 (2): 92-105, 2012 
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differentiation (Lynn and Golenbock, 1992). sCD14 can 
bind  to  circulating  LPS  complexes  and  can  activate 
cells  that  do  not  normally  express  mCD14,  such  as 
CD14-monocytes  and  endothelial  cells  (Golenbock  et 
al., 1995; Schutt et al., 1995).  
  In  HIV  infection,  up-regulated  expression  of 
mCD14 and increased levels of sCD14 on monocytes 
(Lien et al., 1998; Nockher et al., 1994) and alveolar 
macrophages  (Wasserman  et  al.,  1994)  have  been 
reported. Elevated levels of sCD14 have been shown to 
correlate  with  disease  progression  in  cases  of 
HIV/AIDS  (Lien  et  al.,  1998;  Nockher  et  al.,  1994). 
Lien  et  al.  (1998)  studied  serum  levels  of  sCD14  in 
HIV-1 infected individuals. They found that sCD14 has 
an  inverse  correlation  to  CD4+T  cell  counts  and  a 
highly significant correlation with HIV-1 RNA levels in 
serum.  Thus,  sCD14  appears  to  be  associated  with 
advanced  HIV  disease  (Lien  et  al., 1998) This  study 
showed that CD14 was elevated in serum from HIV-1-
infected  individuals  compared  with  seronegative 
controls. The highest levels were found in patients with 
advanced  clinical  and  immunological  disease.  Patients 
with  ongoing  clinical  events  had  significantly  higher 
sCD14  levels  than  symptomatic  HIV-1-infected 
individuals  without  clinical  events,  with  especially 
elevated levels in patients infected with Mycobacterium 
Avium  Complex  (MAC).  Longitudinal  analysis  of 
patients  showed  that  increasing  sCD14  serum 
concentrations per time unit were associated with death. 
By  contrast,  this  was  not  the  case  with  monocyte 
numbers, whereas no differences in CD4+T cell numbers 
were found between survivors and non-survivors.  
  The  molecular  mechanism  through  which 
monocyte  CD14  expression  is  up-regulated  remains 
unclear.  A  recent  study  undertaken  by  Creery  et  al. 
(2002)  showed  that  the  HIV-regulatory  protein  Nef 
upregulated mCD14 expression but fails to induce the 
release  of  sCD14.  Higher  levels  of  mCD14  and 
circulating  sCD14  in  HIV-infected  individuals  may 
reflect their chronic state of inflammation and may be 
involved  in  enhanced  susceptibility  to  gram-negative 
infections (Creery et al., 2002).  
  Recently, it has been shown that in HIV-infected 
patients,  the  amounts  of  MD-2,  CD14  and  IL-10 
increased significantly in the patient group with AIDS. 
Interesting was that IL-10, CD14 and MD-2 levels were 
positively correlated, suggesting that IL-10  may be a 
driving force for increased release of MD-2 and CD14 
during systemic inflammation (Sandanger et al., 2009).  
 
Production  of  cytokines  and  chemokines  by 
monocytes in HIV-1 infection: HIV infection, at all 
stages of the disease, is associated with chronic immune 
activation  and  dysfunctional  cytokine  production 
(Alfano  and  Poli,  2002;  Fantuzzi  et  al.,  2000). 
Monocytes and macrophages are highly secretory cells 
and are therefore major contributors to the alteration of 
the cytokine/chemokine network (Fantuzzi et al., 2003). 
It  is  now  widely  accepted  that  in  HIV-infected 
individuals  there  is  a  decrease  in  the  production  of 
some immuno-regulatory cytokines (interleukin (IL) -2, 
IL-12,  IL-10  and  IFN-γ),  an  increase  in  pro-
inflammatory cytokines (TNF-α, IL-1, IL-6 and IL-8), 
as  well  as  an  increase  in  production  of  type  1 
interferon’s  (IFN’s)  (Gessani  et  al.,  1997).  Several 
reports  have  shown  that  monocytes/macrophages 
produce  a  variety  of  cytokines  in  response  to  HIV 
infection (Alfano and Poli, 2002; Amirayan-Chevillard 
et  al.,  2000;  Gessani  et  al.,  1994).  Some  of  these 
cytokines  have  been  shown  to  up-regulate  HIV 
expression, such as TNF-α, whereas others have been 
shown to be powerful inhibitors of HIV replication in 
macrophages, such as IFN’s.  
  Not only does HIV infection cause a dysfunctional 
cytokine  production,  but  it  also  disrupts  the  normal 
synthesis  of  chemokines.  A  number  of  studies  have 
demonstrated that exposure of monocytes/macrophages 
to  viral  products,  such  as  gp120,  can  trigger  CC 
chemokine  production,  as  well  as  through  pro-
inflammatory  cytokines  inducing  the  production  of 
chemokines  such  as  CCL2  (Badolato  et  al.,  1997). 
CCL2,  CCL3,  CCL4  and  CCL22  have  been 
consistently  detected  in  monocytes  and  monocyte-
derived macrophages (Andrew et al., 1998; Bonecchi et 
al.,  1998;  Godiska  et  al.,  1997).  CC  chemokines  are 
responsible for attracting monocytes and leukocytes to 
sites  of  infection.  When  there  is  an  up-regulation  of 
chemokine  production  it  leads  to  the  abnormal 
movement  of  monocytes  into  various  different  tissue 
sites. It is this situation that possibly drives monocytes 
moving  through  the  blood-brain  barrier  and  causing 
HIV-associated dementia (Yang et al., 2009).  
 
Monocytes-a possible source of HIV during HAART 
therapy: Recent studies have investigated the levels of 
cell-associated  viral  DNA,  mRNA  and  genetic 
evolution of HIV over the course of infection (Sonza et 
al.,  1996;  Zhu,  2002;  Zhu  et  al.,  2002).  Monocytes 
isolated  from  blood  have  been  shown  to  contain  un-
integrated  circular  viral  DNA  and  multiply  spliced 
RNA  suggesting  their  infection  is  recent  and 
transcriptionally active rather than latent (Sonza et al., 
1996). Zhu and colleagues observed that blood-purified 
monocytes  harboured  HIV  DNA  over  time  in  both 
untreated  and  therapy-suppressed  individuals  (Zhu  et 
al.,  2002).  In  a  recent  study,  Potter  and  Colleagues Am. J. Infect. Dis., 8 (2): 92-105, 2012 
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presented  a  detailed  analysis  of  HIV-1  populations 
isolated  from  total  PBMC,  plasma,  CD4+T  cells, 
CD8+T  cells  and  monocytes/macrophages  in  13 
patients  receiving  HAART.  Sequence  analysis  of  the 
reverse transcriptase and protease genes indicated that 
viral  strains  isolated  from  different  blood  leukocytes 
were  genetically distinct in each subject. Further, the 
compartmentalization  of  drug  resistance  mutations  in 
specific blood cell types was observed in approximately 
50% of patients. The prevalence of resistance mutations 
was  higher  in  either  CD4+T  cells  or 
monocytes/macrophages  in  these  subjects.  However, 
CD8+T  cells  showed  markedly  lower  levels  of  viral 
drug resistance in  these patients,  indicating a lack of 
viral replication in this compartment. This study is the 
first to demonstrate the differential distribution of HIV 
drug  resistance  in  different  blood  cell  types  during 
HAART and provides new insights into the infection of 
diverse blood leukocytes, including monocytes in vivo 
(Potter et al., 2003; Saksena and Potter, 2003).  
  Viral decay in monocytes was considerably slower 
on average  than that in activated and resting  CD4+T 
cells. In addition, the average half-life of HIV DNA in 
monocytes was considerably longer than the estimated 
mean  inter-mitotic  life  spans  of  monocytes  and 
macrophages  (Perelson  et  al.,  1996;  1997;  Whitelaw 
and Batho, 1972; Furth, 1989), suggesting renewal of 
the virus as a result of continued viral replication (Zhu 
et  al.,  2002).  A  significant  genetic  evolution  in 
monocytes was also observed and in some individuals 
on  suppressive  therapy  monocyte  trains  were 
phylogenetically-linked  with  circulating  plasma 
variants (Zhu et al., 2002). These findings suggest that 
monocytes  may  constitute  a  continuing  source  of 
infectious virus during HAART regardless of the length 
of treatment.  
  As  discussed  above,  the  circulating  monocyte 
population  is  heterogeneous  consisting  of  several 
subsets. The majority express high levels of CD14 and 
little or no CD16, termed as CD14hi. A minor subset 
representing around 15% of total circulating monocytes 
expresses low levels of CD14 and high levels of CD16 
(CD14loCD16hi)  (Passlick  et  al.,  1989). 
CD14loCD16hi  monocytes  may  represent  a  stage  in 
myeloid  maturation,  either  to  tissue  macrophages  or 
immature  dendritic  cells.  CD14loCD16hi  monocytes 
share  some  similarities  with  mature  monocytes 
including their cytokine profiles (Passlick et al., 1989) 
and are major producers of tumor necrosis factor alpha 
(TNF-α) in the blood (Belge et al., 2002). They also 
share  similarities  with  dendritic  cells  (Ancuta  et  al., 
2000).  The  CD14loCD16hi  subset  expresses  elevated 
levels of CCR5 (Weber et al., 2000) and CD4 (Tanaka 
et al., 1999) in comparison to CD14hi monocytes. The 
characteristics  of  the  CD14loCD16hi  subset  suggest 
they  may be the  major targets of HIV.  Although the 
actual  source  of  HIV-1  in  these  monocytes  remains 
undefined, there is evidence that HIV-1 proviral DNA 
in  monocytes  does  not  originate  from  myeloid  tissue 
precursors (Spear et al., 1990).  
  The normal pathways of monocyte migration and 
trafficking may also define a mechanism by which HIV 
is distributed to various compartments around the body. 
After leaving the bone marrow, monocytes remain in 
the circulation for between two and four days before 
migrating  through  the  endothelial  walls  of  capillaries 
(Whitelaw  and  Batho,  1972)  and  undergoing 
differentiation  into  tissue  macrophages.  Alternatively 
they may differentiate into Dendritic Cells (DCs) and 
enter the lymphatics (Harmsen et al., 1985; Randolph et 
al., 2002). HIV-infected monocytes can thus migrate to 
a  variety  of  different  sites  around  the  body  and  are 
likely to be responsible for colonization and continued 
turnover  in  diverse  tissue  compartments  such  as  the 
CNS (Nottet et al., 1996; Persidsky et al., 1999). The 
early establishment of HIV infection in monocytes and 
the ongoing replication and persistence of HIV in this 
compartment  represents  a  considerable  challenge  for 
antiretroviral drug regimens. 
 
Functional changes in monocytes caused by HIV-1: 
Although  monocytes are  not substantially depleted in 
HIV  infection,  alterations  of  function  have  been 
recognized for many years. It has been well established 
that  these  functional  effects  play  important  roles  in 
neurological disease, in AIDS and in defective innate 
immunity (Collman et al., 2003). 
 
Monocyte differentiation and HIV infection: Blood-
circulating monocytes differentiate in tissues into either 
macrophages  or  dendritic  cells  in  both  a  response  to 
danger  stimuli  or  to  replenish  resident  cells  under 
normal conditions. Due to their migratory behavior and 
their key functions in immune system responses, it is 
not surprising that cells of the  monocyte-macrophage 
lineage are often the preferential targets of a number of 
lentiviruses.  Although  a  vast  literature  exists  on  the 
ability of HIV-1 to replicate in either macrophages or 
dendritic cells (Collman et al., 2003; Kedzierska et al., 
2003b;  Verani  et  al.,  2005),  blood-circulating 
monocytes are often considered as an example of a cell 
type restrictive to HIV-1 infection (Heinzinger et al., 
1995; Neil et al., 2001; Sonza et al., 1996). Given that 
infectious  virus  can  be  isolated  from  monocytes  of 
seropositive patients (Collman et al., 1989), it is clear 
that monocytes, although resistant, are not completely Am. J. Infect. Dis., 8 (2): 92-105, 2012 
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refractory  to  HIV  infection.  Thus,  cellular 
differentiation  of  monocytes  to  macrophages  plays  a 
role in increasing the susceptibility of monocytic cells 
to  viral  infection  and/or  enhancing  HIV  expression 
from cells harboring HIV provirus (Goletti et al., 1995). 
As  mentioned  below,  monocytes  up-regulate  the 
expression  of  TLR’s  in  response  to  HIV  infection. 
Krutzik et al. (2005) took these findings and explored 
the  role  of  TLR’s  in  monocyte  differentiation.  They 
showed that the activation of TLR’s causes the rapid 
differentiation  of  monocytes  into  either  DC-SIGN+or 
CD1b+cells  (Krutzik  et  al.,  2005).  DC-SIGN+cells 
have a macrophage-like phenotype, are phagocytic and 
use  DC-SIGN  to  facilitate  the  uptake  of  bacteria.  In 
contrast, CD1b+cells have an immature dendritic cell 
phenotype,  release  pro-inflammatory  cytokines  and 
function as effective antigen-presenting cells.  
  Like  T  cells,  macrophages  display  immune 
polarization  that  can  promote  or  impair  adaptive 
immunity.  Fischer-Smith  et  al.  (2008)  have 
hypothesized  that  dysregulation  of 
monocyte/macrophage  activation  and  differentiation 
may  promote  immune  dysfunction  and  contribute  to 
AIDS  pathogenesis.  Using  flow  cytometry,  they 
analyzed the frequency of monocyte subsets in HIV-1 
infection relative to seronegative controls, focusing on 
the CD163(+)/CD16(+) monocyte as a likely precursor 
of the "alternatively activated" macrophage. Individuals 
with detectable HIV-1 infection showed an increase in 
the frequency of CD163(+)/CD16(+) monocytes when 
compared  to  seronegative  or  HIV-1-infected  persons 
with  undetectable  viral  loads.  A  positive  correlation 
was  observed  between  increased  CD163(+)/CD16(+) 
monocyte frequency and plasma viral load. These data 
suggest  a  potential  role  for  CD163(+)/CD16(+) 
monocytes in virus production and disease progression. 
CD163(+)/CD16(+)  monocytes  may  be  a  useful 
biomarker for HIV-1 infection and AIDS progression 
and  a  possible  target  for  therapeutic  intervention 
(Fischer-Smith et al., 2008).  
 
Expression of Toll-Like Receptors (TLRs): Receptors 
of the innate immune system are crucial in the first-line 
defense against foreign microbes and are important for 
modulating  the  adaptive  immune  response.  TLRs 
represent  an  important  category  of  such  pathogen-
recognition  receptors.  Monocytes  have  been  shown  to 
express TLR-2 and TLR-4 and the stimulation of these 
receptors  induces  the  activation  of  NFκB,  with 
subsequent  production  of  inflammatory  cytokines  and 
chemokines (Heggelund et al., 2004). Heggelund and his 
colleagues in 2004 demonstrated that there is an increase 
in TLR-2 expression on monocytes during HIV infection 
(Heggelund et al., 2004). After stimulation of Peripheral 
Blood Mononuclear Cells (PBMC’s) with gp120, there 
was  a  significant  increase  in  TLR-2  expression  on 
monocytes,  supporting  a  possible  link  between  HIV 
infection and TLR-2 expression.  
  Many  studies  have  shown  that  ongoing  Tumor 
Necrosis  Factor  (TNF)  production  is  seen  in  HIV 
infected patients even during HAART (Aukrust et al., 
1999; Ledru et al., 2000). With the increase of TLR-2 
expression  on  monocytes  and  the  persistent  TNF-α 
presence, it leads to an increase in inflammation effects. 
Therefore,  the  increase  in  TLR-2  expression  on 
monocytes  could  contribute  to  HIV-related 
inflammation. 
 
Relevance of monocytes in HIV disease:  
Viral  reservoir:  Mononuclear  phagocytes  (bone 
marrow  monocyte-derived  macrophages,  alveolar 
macrophages, perivascular macrophages and microglia) 
are reservoirs and vehicles of dissemination for HIV-1. 
Infected  monocytes  can  seed  HIV  in  down-stream 
lineage  cells,  namely  macrophages,  which  can  then 
serve as a virus source in multiple tissue sites (Fulcher 
et al., 2004). Despite whether HIV-1 can replicate in 
monocytes  themselves,  once  the  cell  has  entered  a 
tissue site and differentiated into either a macrophage or 
dendritic cell, then the virus can start replicating and 
infecting the tissue. Tissue macrophages are generally 
regarded  as  more  important  long-lived  reservoirs  and 
these cells often support high levels of viral replication. 
Macrophages have been shown to act as a virus source 
in non-lymphoid tissues such as the brain, lung, liver 
and gut (Orenstein et al., 1997). These cellular reservoirs 
and tissue sanctuary sites allow either continuing low-
level  viral  transcription,  or  are  latently  infected  and 
contain integrated proviral DNA. Furthermore, all known 
reverse  transcriptase  inhibitors  are  ineffective  in 
chronically infected macrophages, which accentuates the 
viral persistence in these tissue sites and highlights the 
importance  of  this  role  of  monocytes  in  HIV-1 
pathogenesis (Aquaro et al., 1997).  
  Recently, Gibellini et al. (2008) evaluated HIV-1 
DNA loads in Peripheral Blood Leukocytes (PBLs) and 
monocytes  from  long-term  HAART-treated  and 
antiretroviral  naïve  HIV-1  infected  patients  and 
compared to RNA viral load and CD4+cell count. Their 
analysis  revealed  that  the  HAART-treated  patients 
showed significantly lower levels of viral DNA both in 
PBLs and  monocytes in comparison to therapy  naïve 
individuals. Variable levels of HIV-1 DNA amount in 
monocytes were detected in all naïve patients but only 
in  12  of  34  HAART-treated  individuals.  Their  work 
confirms that the long-term HAART decreased HIV-1 
DNA  load  in  PBLs  and  monocytes  demonstrating  a 
valuable  inhibitor  effect,  especially  in  short-lived Am. J. Infect. Dis., 8 (2): 92-105, 2012 
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reservoirs. In addition, the positive correlation of DNA 
burden  between  PBLs  and  monocytes  may  suggest  a 
dynamic relation between these reservoirs in the course 
of disease (Gibellini et al., 2008).  
 
Monocytes and HAART: HIV-1 in blood monocytes 
can disseminate and evolve independently from CD4+T 
cells over the course of HIV-1 infection. This presents a 
major  challenge  to  the  treatment  of  HIV-1  infection 
because  HIV-1  populations  in  monocytes  and 
macrophages are poorly suppressed, compared to those 
in  CD4+T  cells  and  replicate  relatively  actively  in 
patients  undergoing  seemingly  effective  HAART 
(Fulcher et al., 2004). Zhu et al. (2002) showed that 
HIV-1 can replicate in CD14+monocytes in vivo, even 
in  patients  receiving  HAART  (Zhu  et  al.,  2002). 
Monocytes/macrophages  can  maintain  HIV-1 
replication  even  throughout  HAART,  because  the 
antiretroviral drugs may not block viral replication in 
these  cells  as  efficiently  as  in  CD4+T  cells.  This  is 
because  cells  from  the  monocyte/macrophage  lineage 
have quite different characteristics to lymphocytes, in 
terms of cellular metabolism, membrane receptors and 
responsiveness to cytokines (Aquaro et al., 1997).  
  Aquaro et al. (1997) performed a comprehensive 
assessment of the effects of most antiretroviral drugs on 
both  lymphocytes  and  monocyte/macrophages.  They 
found  that  all  clinically  relevant  nucleoside  analogue 
inhibitors of reverse transcriptase were more effective 
in  monocyte/macrophages  then  in  lymphocytes. 
However, these drugs have limited effect against HIV-
related encephalopathy because of the poor penetration 
of these drugs into the central nervous system, rather 
than  their  limited  effect  on  HIV-infected 
monocytes/macrophages.  Protease  inhibitors  were 
found to be the only drug able to affect the replication 
of HIV in monocytes/macrophages already carrying the 
proviral genome. However, it is unknown as to whether 
protease inhibitors in plasma and issues maintain high 
enough  concentrations  to  be  active  on  chronically 
infected cells (Aquaro et al., 1997). Therefore, future 
drugs  targeting  monocytes/macrophages  should  be 
aimed at the later stages of HIV life cycle.  
 
Monocytes supporting HIV persistence in vivo: HIV-
1  is  often  continually  present  in  the  body  despite 
ongoing  HAART  therapy.  Three  models  have  been 
proposed to account for HIV-1 persistence in relation to 
monocytes.  The  first  model  is  based  on  monocytes 
serving as a direct source of plasma virus by producing 
infectious  HIV-1  in  peripheral  blood  (Zhu,  2002).  In 
patients  without  antiretroviral  therapy,  activated 
CD4+T  cells  may  produce  up  to  99%  of  all  virus 
particles while the other 1% of virus may be generated 
primarily  from  tissue  macrophages.  In  this  situation, 
viruses produced by blood monocytes may be too minor 
to  recognize.  However,  in  patients  on  suppressive 
HAART in whom HIV replication in activated CD4+T 
cells  is  blocked,  viruses  produced  from  monocytes 
become  relatively  dominant.  Zhu  (2002)  showed  that 
there  was  a  higher  level  of  HIV-1  replication  in 
CD14+monocytes compared with resting CD4+T cells 
in  patients  undergoing  HAART  (Zhu,  2002).  This 
demonstrates that monocytes can contribute to plasma 
virus and therefore contribute to HIV persistence within 
the infected individual.  
  The second model to account for the persistence of 
HIV-1  in  blood  monocytes  is  that  HIV-infected 
precursor cells of monocytes in bone marrow enter and 
renew HIV-1 infected monocytes in peripheral blood. 
These  monocyte  precursor  cells,  namely 
CD34+progenitor  cells,  may  be  infected  with  HIV, 
then enter the bloodstream and renew the viral pool 
in  peripheral  blood  monocytes.  However,  there  is 
much controversy in this area of investigation, as it 
is still unknown as to whether CD34+progenitor cells 
are  susceptible  to  HIV-1  infection  (Alexaki  and 
Wigdahl, 2008).  
  The third model for HIV-1 persistence is that HIV-
infected monocytes can act as a viral reservoir or viral 
source,  as  discussed  previously.  These  viral  sources 
maintain  HIV-1  in  sites  most  often  inaccessible  to 
HAART and contribute to HIV-persistence.  
 
HIV  Neuropathogenesis:  Monocyte-macrophage 
trafficking  through  the  blood  brain  barrier:  An 
interesting aspect of the previously mentioned role of 
monocytes as viral reservoirs is in neuropathogenesis 
related  to  HIV.  HIV-1  enters  the  brain  during  the 
establishment  and  systemic  dissemination  of  HIV-1 
infection and causes a broad range of HIV-1 associated 
neurocognitive  disorders,  including  HIV-1-Associated 
Dementia (HAD) in at least 30% of HIV patients. Even 
in the era of HAART, HAD continues to be a problem 
because of suboptimal concentrations of drugs reaching 
the  CNS.  HAD  is  a  devastating  neurological  disease 
which is characterized by typical pathological changes 
in the brain and spinal cord. HIV-induced changes in 
the brain are most evident in the white matter and they 
include  gross  cerebral  atrophy  without  inflammation, 
but  associated  with  microglial  nodules  (clusters  of 
microglia  and  reactive  fibrous  astrocytes)  and 
multinucleated giant cells (Meltzer et al., 1990).  
  There  is  now  general  agreement  that  the  cells 
supporting  productive  infection  in  brain  are  the Am. J. Infect. Dis., 8 (2): 92-105, 2012 
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microglial cells and macrophages, whereas the neurons 
and  oligodendrocytes  are  relatively  rarely  infected 
(Bagasra  et  al.,  1996).  The  route  of  CNS  infection 
appears  to  involve  Circulating  Activated  Monocytes 
(CAM),  which  increase  in  proportion  as  the  disease 
stage of an individual progress (Gartner, 2000; Pulliam 
et  al.,  1997).  The  peripheral  activation  of  circulating 
monocytes  is  the  critical  step  for  viral  entry  into  the 
CNS  (Gartner,  2000).  It  has  been  shown  that 
individuals seropositive for HIV may contain little or 
no  DNA,  despite  early  entry  of  HIV  into  the  brain 
(Donaldson et al., 1994). Even if DNA is evident, there 
is no expression of HIV structural proteins (Kibayashi et 
al., 1996). Thus, the reseeding of the CNS by activated 
monocytes leading to productive CNS infection remains 
the  only  plausible  mechanism  of  viral  entry  into  the 
brain,  which,  in  most  cases,  does  not  occur  until  an 
advanced stage of HIV disease (Kim et al., 2003).  
  Further, macrophage activation within the CNS and 
Peripheral  Nervous  System  (PNS)  appears  to  be  a 
critical factor in the development of HIV-D and sensory 
neuropathies  (Keswani  et  al.,  2002).  Since  the 
emergence of a subset of circulating monocytes during 
HIV-1  disease  appears  to  correlate  with  cognitive 
impairment,  it  has  been  hypothesized  that  diagnostic 
protein profiles may be obtained from this monocytic 
subset especially for patient at risk for HIV-D. Wojna et 
al.  (2004)  with  the  help  of  sophisticated  proteomic 
techniques (surface enhance laser desorption/ionization-
time of flight protein chip assay) have elegantly shown 
with a case study seven unique proteins between 3 and 
20 kD in Monocyte-derived Macrophges (MDM) from 
patients with HIV Associated Dementia (HAD), which 
were  absent  in  the  control  group.  Further,  all  these 
proteins were abrogated after HAART. Recently, (Sun 
et  al.,  2004)  have  also  shown  that  there  is  loss  of 
macrophage-secreted lyzozyme in HIV-D as shown 
by  SELDI-TOF  mass  spectrometry.  Thus,  both 
studies  confirm  macrophage  dysfunction  as  a 
significant consequence to HAD and both emphasize 
the  utility  of  MDM profiling  for the diagnosis  and 
monitoring of HIV-D.  
 
Viral inflammation and replication: Monocytes play 
a crucial role in the early innate immunity response to 
all infections. They recognize non-self molecules and 
through the release of cytokines and chemokines they 
can  stimulate  other  immune  cells,  as  well  as  the 
adaptive immune response, to clear the infection. These 
cytokines  and  chemokines  can  also  affect  viral 
replication  and  even  pathogenesis,  however  the 
contribution of monocytes to viral replication remains 
unclear.  Kuwata  et  al.  (2007)  showed  that  monocyte 
cell  count  has  a  close  relation  to  viral  load.  This 
suggests that monocytes have significant effects on viral 
replication in vivo and that monocytes may play a role in 
controlling  viral  replication  in  the  early  phase  of 
infection  (Kuwata  et  al.,  2007).  In  the  later  stages  of 
disease, monocytes may not have such an effect on viral 
replication  or  progression  of  disease  because  in  this 
phase adaptive immunity plays the main role.  
  Recently,  interest  has  grown  around  whether 
monocytes  can  harbor  replicative-petent  HIV-1.  A 
study by Crowe et al. (2003) showed that monocytes 
contain  HIV-1  DNA  in  both  untreated  and  treated 
patients.  Furthermore,  viral  decay  in  monocytes  was 
slower  on  average  than  that  in  activated  and  resting 
CD4+T cells and the mean half-life of HIV-1 DNA in 
monocytes was longer then that in resting and activated 
CD4+T cells (Crowe et al., 2003). This suggests that 
either  the  blood  monocytes  are  recently  infected,  or 
there is ongoing viral replication in monocytes or in its 
precursor cells. This finding is controversial, as there 
have also been a number of studies that have showed 
that monocytes are unable to release HIV-1 virions.  
 
CD14+monocyte  transcriptome  and  its  subversion 
by HIV: There has been much interest surrounding the 
role  that  monocytes  play  in  HIV-1  pathogenesis 
because of their seemingly crucial role in combating the 
infection. One recent method for studying these cells is 
by analyzing their gene expression at different stages of 
HIV-1  disease.  This  form  of  method  hopes  to  reveal 
important genes or proteins that will define the role that 
monocytes play in HIV-1 pathogenesis and gain to our 
understanding  of  HIV-1  to  hopefully  create  more 
efficient  treatment  regimes.  Giri  and  his  colleagues 
performed  one  such  study  in  early  2009,  where  they 
analyzed the gene expression of circulating monocytes 
in  HIV-1  infected  subjects.  They  studied 
HIV+ndividuals with viral loads of between 3000 and 
100000 copies ml
-1 of plasma and who were untreated 
patients.  After  microarray  analyses,  there  were  a 
number of genes  found to be differentially regulated, 
but  they  chose  to  focus  on  apoptosis-related  genes 
because  they  were  significantly  over-represented  by 
functional group clustering analysis. In this group there 
were 58 genes in total and 38 of these genes have been 
directly  reported  as  having  pro-and  anti-apoptotic 
function.  Of  these  38  genes,  28  of  them  were  stably 
modulated to suggest increased monocyte survival, i.e., 
pro-apoptotic  genes  were  down  regulated,  or  anti-
apoptotic genes were up regulated. Through functional 
analysis, Giri and her colleagues also showed that these Am. J. Infect. Dis., 8 (2): 92-105, 2012 
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genes  are  associated  with  four  pathways,  being  p53 
modulation,  TNF  signaling,  CD40L  signaling  and 
MAPK signaling (Giri et al., 2009).  
  Giri and her colleagues  were the first to provide 
evidence of a stable anti-apoptosis gene expression in 
monocytes in chronic HIV-1 infection. However, this 
study  only  tested  14,000  genes  from  the  human 
genome.  There  have  been  no  studies  performed  on 
monocytes in HIV-1+patients, 1 which encompass all 
25,000 human genes, therefore the studies by Giri et al. 
(2009) are preliminary.  
 
Monocyte-derived macrophage secretome: Very little 
appears to have been explored at the level of monocyte 
proteome  in  the  context  of  HIV  infection.  To 
understand HIV and its interaction with monocytes, a 
clear understanding of correlation between trancriptome 
and proteome is necessary in order to validate if some 
transcripts are also expressed at the protein level. This 
can  further  provide  functional  validation  and  identify 
protein candidates, which may possibly be involved in 
HIV pathogenesis of monocytes. Recently, Ciborowski 
et al. (2007) analyzed the secretome of HIV-1-infected 
human monocyte-derived macrophages. They identified 
110  proteins  in  culture  supernatants  of  control 
(uninfected)  and  virus-infected  cells.  Differentially 
expressed  cytoskeletal,  enzymes,  redox  and 
immunoregulatory  protein  classes  were  discovered, 
which  were  validated  by  Western  blot  tests.  These 
included  cystatin  C,  cystatin  B,  chitinase  3-like  1 
protein,  cofilin-1,  l-plastin,  superoxide  dismutase, 
leukotrieneA(4) hydrolase and alpha-enolase. Although 
this study, using high throughput proteomic approach, 
provides  insights  into  virus-host  cell  interactions  that 
likely  affect  the  functional  role  of  monocyte-derived 
macrophages  in  HIV  disease,  detailed  studies  are 
needed  to  validate  these  data  on  primary  monocytes 
from HIV patients at different stages of HIV disease, 
which may provide a snapshot of proteins relevant in 
vivo.  The  studies  by  Ciprowski  will  provide  a  good 
comparison against primary monocytes.  
 
CONCLUSION 
 
  The functional improvement of monocytes, which 
are  one  of  the  critical  components  of  the  innate 
antimicrobial  immunity,  is  likely  to  contribute  to  the 
improved cell-mediated immunity against opportunistic 
infections  in  HIV  patients  receiving  HAART.  More 
work is needed at the cell subset level to define which 
monocytic subsets are impaired during HIV viremia, so 
that  functional  restoration  can  be  achieved  through 
appropriate  interventions  in  HIV  patients  to  improve 
cell-mediated immune responses.  
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